The global medical foods market size was valued at USD 20.2 billion in 2020, and is predicted to be worth around USD 32.5 billion by 2030, registering a CAGR of 5.1% during the forecast period 2022 to 2030.
Increasing incidences of chronic diseases, the rising geriatric population, and the growing burden of malnutrition are the major factors responsible for the substantial growth of the market over the years. For instance, according to a WHO report, about 149 million children under 5 were stunted and 38.9 million were obese or overweight due to undernutrition in 2020. The emerging focus of the policymakers to manage chronic disorders and nutritional deficiency is also anticipated to drive the adoption of medical foods over the years.
The growing prevalence of communicable and non-communicable diseases and increasing effort for the dietary management of those diseases are anticipated to propel the market growth over the forecast years. For instance, as per the research data published by the University of Liege, it has been estimated that in Europe, the sarcopenia population will increase to 12.9% by 2045 from 11.1% in 2016.
|Market Size||US$ 32.5 billion by 2030|
|Growth Rate||CAGR of 5.1% From 2022 to 2030|
|Largest Market||North America|
|Forecast Period||2022 to 2030|
|Segments Covered||Route of administration, Product, Application, Sales Channel|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, Middle East & Africa|
|Companies Mentioned||AT&T; Samsung Electronics Co.; Allscripts Healthcare Solutions; Apple, Inc.; Orange; mQure; Qualcomm Technologies, Inc.; SoftServe; Google, Inc, Airstrip Technologies, Inc.; Telefonica S.A.; Vodafone Group|
By Product Analysis
The powder segment accounted for the largest revenue share of over 35.0% in 2021 owing to the high commercial availability of medical foods in the form of powder. In addition, increasing preference and ease in consumption by the pediatric and geriatric patients suffering from different chronic diseases are fueling the segment growth.
The liquid segment is anticipated to grow at the fastest rate during the forecast period owing to the rising adoption of liquid formulations in the pediatric and geriatric population, where the intake of solid formulations is limited or impossible and in case of clinically diagnosed dysphagia or when oral physiology is limited.
By Application Analysis
Chemotherapy-induced diarrhea accounted for the largest revenue share of over 15.0% in 2021. Diarrheal episodes interfere with the chemotherapy process and dosage pattern. Therefore, the rising need for adopting medical foods in dietary management is expected to boost the segment growth.
Because of loss of absorptive surfaces and potential mucosal damage due to chemotherapy-related diarrhea, patients should ingest specific easy-to-digest medical food, which is expected to fuel the segment growth over the forecast years.
Diabetic neuropathy is anticipated to be the fastest-growing segment over the forecast period owing to the growing prevalence of diabetes and a rise in the number of patients that are at risk of developing some level of neuropathy.
The growing number of patients suffering from diabetic neuropathy and increasing prescription by medical professionals for medical food consumption to manage the disease are the major factors propelling the segment growth. The growing prevalence of diabetic neuropathy all over the globe is further supporting the growth of the segment.
By Sales Channel Analysis
The institutional sales channel, which includes hospitals, home care settings, and disability facilities, accounted for the largest revenue share of over 40.0% in 2021. The growing number of patient visits to the hospitals and other healthcare facilities for the diagnosis and treatment of several chronic and dietary disorders is driving the segment.
The increasing preference among the patients to consult a doctor in the hospitals for their chronic disease management will drive the segment. Moreover, the growing number of private and public healthcare institutions and the increasing chronic disease patient population across the globe will support the segment growth.
The online sales segment is anticipated to expand at the fastest rate over the forecast period. Preference for the online purchase of medical foods is rising owing to the convenience offered by this sales channel. Although medical foods are mainly consumed under medical surveillance, these are intended for long-term nutrition management, which is resulting in surging sales through e-commerce.
By Regional Analysis
North America held the largest revenue share of over 30.0%. The presence of international companies such as Abbott Laboratories and Mead Johnson & Company and the high revenue generation of these companies are driving the market.
The Asia Pacific region is anticipated to be the fastest-growing regional market over the forecast period owing to the increasing rate of cancer and diabetic patients, along with several government initiatives in the healthcare segment.
Johnson & Johnson Pte. Ltd. company, Asia Pacific hosts about 50% of new cancer cases in the world each year. Further, this report stated that the death due to cancer is estimated to increase by 36% in the Asia Pacific region by 203o, which, in turn, is expected to propel the growth of the market in this region over the coming years.
Mead Johnson & Company, LLC
Targeted Medical Pharma, Inc.
Primus Pharmaceuticals, Inc.
By Route of Administration
Chronic Kidney Disease
Minimal Hepatic Encephalopathy
Chemotherapy Induced Diarrhea
Pathogen Related Infections
Other Cancer related treatments
Severe protein allergy
By Sales Channel
Middle East & Africa
The medical foods market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of medical foods market for the base year 2021 and the forecast between 2022 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global medical foods market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the medical foods market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted medical foods market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the medical foods capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of medical foods by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global medical foods market. These figures have been provided in terms of both revenue and volume for the period 2019 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major medical foods market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of medical foods market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the medical foods industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
medical foods market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to medical foods market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of medical foods market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new medical foods market. These factors have benefited the growth of the global market for medical foods. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for medical foods. The global market is segmented on the basis of region, application, end-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of medical foods are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Trauma Care Centers Market (By Facility Type: In-house, Standalone; By Trauma Type: Falls, Traffic-related Injuries; By Service Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Monkeypox Vaccine And Treatment Market (By Product: Vaccine, Drugs) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Hyaluronic Acid Market (By Application: Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
AI in Oncology Market (By Treatment: Chemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Gene Therapy; By Cancer Type; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Paracetamol IV Market (By Application: Surgical, Non-surgical; By Indication: Pyrexia, Pain; By End-use: Hospitals, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...